Drug intelligence / Profile preview

WGc-0401

Development stage
Phase 1
Lead developer
Chengdu Weisijin Biopharmaceutical Technology
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

WGc-0401 is an investigational mRNA-based vaccine developed by WestGene Biopharma for the prevention of Epstein-Barr virus (EBV)-related diseases. It is specifically designed for use in immunocompromised populations, such as patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), who are at high risk for EBV reactivation, viremia, and post-transplant lymphoproliferative disorders (PTLD). The vaccine delivers mRNA encoding EBV-specific glycoprotein antigens to host cells, which then produce these antigens to stimulate both humoral (neutralizing antibodies) and cellular (EBV-specific T-cell) immune responses. By enhancing EBV-specific immunity post-transplant, WGc-0401 aims to reduce the incidence of severe viral complications and improve clinical outcomes in transplant recipients.

Other names
EBV mRNA vaccine

Beyond the preview

Go deeper on WGc-0401.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WGc-0401.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call